HIV\/AIDS is a chronic, manageable infection that affects millions of people worldwide. While there is no cure for HIV\/AIDS, there are effective treatments available that can help manage the disease and improve the quality of life for those living with it. In this article, we’ll explore the various treatments available for HIV\/AIDS.<\/p>\n\n\n\n
The cornerstone of HIV\/AIDS treatment<\/strong><\/em><\/a>\u00a0is antiretroviral therapy<\/strong><\/em> (ART). ART involves taking a combination of medications that target the virus at various stages of its life cycle. These medications inhibit the virus’s ability to replicate and spread throughout the body. With ART, people living with HIV can achieve viral suppression, which means that the virus is undetectable in their blood. This not only improves their health outcomes but also reduces the risk of transmission to others.<\/p>\n\n\n\n There are several classes of antiretroviral drugs available, including:<\/p>\n\n\n\n Tenofovir alafenamide Taf \/ Emtricitabine FTC: <\/strong>These drugs interfere with the virus’s ability to replicate its genetic material.<\/p>\n\n\n\n Efavirenz: <\/strong>These drugs bind to the reverse transcriptase enzyme, which is necessary for the virus to replicate.<\/p>\n\n\n\n Darunavir \/ <\/strong>Ritonavir: <\/strong>These drugs inhibit the protease enzyme, which is necessary for the virus to assemble new virions.<\/p>\n\n\n\n Dolutegravir \/ Bictegravir: <\/strong>These drugs inhibit the integrase enzyme, which is necessary for the virus to integrate its genetic material into the host cell’s DNA.<\/p>\n\n\n\n Enfuvirtide: <\/strong>This prevents HIV from entering the CD4 cell.<\/p>\n\n\n\n Maraviroc: <\/strong>This drug blocks the virus from entering the host cell.<\/p>\n\n\n\n Cobicistat: <\/strong>These drugs increase the effectiveness of other antiretroviral medications by inhibiting enzymes that break them down.<\/p>\n\n\n\n It’s important to note that ART<\/strong><\/a> is not a one-size-fits-all treatment. The medications prescribed will depend on a person’s viral load, CD4 cell count, and other factors. People with HIV\/AIDS should work closely with their healthcare providers to develop an individualized treatment plan.<\/p>\n\n\n\n Find govt. ART centers in India https:\/\/www.naco.gov.in\/living-hivaids\/list-art-center<\/a><\/p>\n\n\n\nNucleoside\/nucleotide reverse transcriptase inhibitors (NRTIs): <\/strong><\/h3>\n\n\n\n
Non-nucleoside reverse transcriptase inhibitors (NNRTIs):<\/strong><\/h3>\n\n\n\n
Protease inhibitors (PIs):<\/strong><\/h3>\n\n\n\n
Integrase inhibitors (INSTIs):<\/strong><\/h3>\n\n\n\n
Fusion inhibitor:<\/strong><\/h3>\n\n\n\n
Entry inhibitor:<\/strong><\/h3>\n\n\n\n
Pharmacokinetic enhancers:<\/strong><\/h3>\n\n\n\n
Pre-exposure prophylaxis (PrEP)<\/strong><\/h2>\n\n\n\n